FREE Membership Sign in

JavaScript is disabled in your browser.

In order visualise this page, please follow these steps.

Barriers remain to wider acceptance of pharmacogenomic testing

Visibility360, PDF version to share

By Kate McCaffery | Feb. 13, 2024, 10:26 a.m.

Slow uptake attributed to the fact that tests are new, not standardized and unregulated.

This article is reserved to PRO Level subscribers

Discover the PRO Level

The most popular in Health

Mental Health challenges: Effective solutions often overlooked

Seniors least likely to have dental insurance

Global healthcare reinsurance premiums continue to rise

Make your business shine with Visibility360!

Get a PDF version to share in your networks.

I'm interested

Headlines

Construction insurance capacity grows while pricing remains stable

Marine insurers particularly exposed to geopolitical risks

Self-reported mental health declines among children

Related topics …

Flash

Construction insurance capacity grows while pricing remains stable

Marine insurers particularly exposed to geopolitical risks

Self-reported mental health declines among children

European cross-border medicine example touted as a solution for Canada

MANULIFE

Investors concerned about major US companies’ stock performance

Economic uncertainty fails to dampen Canadian life insurers' performance

Managing change and transformational initiatives

Manulife net income flat in second quarter

TELUS

Pensions continue derisking

Mental Health challenges: Effective solutions often overlooked

Novo Nordisk's new anti-obesity drug spurs high demand

Pension investment returns positive in the second quarter of 2024

Distribution

Managing general agencies: A closer look at Ontario’s proposed licensing requirements

Life insurance application activity climbs in Canada

Co-operators General reports $96 million profit in second quarter

Intact nearly triples profit in Q2 2024

Analytic

Canadian life application activity flat in August

Actuaries climate index rose in early 2024

Nearly half of Canadians have difficulty meeting day-to-day expenses

Empire Life posts net income of $35 million for the second quarter of 2024

Medication

Last province in Canada implements biosimilar switching policy

Applicants with eating disorders in their history could still be a good risk

Health Canada takes on appropriate medication use

Ozempic: New indications and off-label prescribing pressure insurance plans